Compugen Ltd. (CGEN) vs Nautilus Biotechnolgy, Inc. (NAUT)
A side-by-side comparison of Compugen Ltd. and Nautilus Biotechnolgy, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGEN
Compugen Ltd.
$2.28HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
NAUT
Nautilus Biotechnolgy, Inc.
$1.95HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
Total return — CGEN vs NAUT
growth of $100 · dividends reinvested · last 6yCGEN -85.9% (-27.8%/yr)NAUT -82.1% (-24.9%/yr)NAUT compounded faster over this window
CGEN NAUT
CGEN vs NAUT: by the numbers
- •NAUT is the larger company ($249M vs $216M market cap).
- •CGEN is profitable (47.55% net margin) while NAUT runs a net loss (-29747.89%).
Metrics side by side
Valuation
| Metric | CGEN | NAUT |
|---|---|---|
| P/E ratio | 6.07 | N/A |
| P/S ratio | 2.91 | 1307.92 |
| P/B ratio | 2.43 | 1.90 |
Profitability
| Metric | CGEN | NAUT |
|---|---|---|
| Gross margin | 86.89% | 0.00% |
| Operating margin | 40.94% | 0.00% |
| Net margin | 47.55% | -29747.89% |
| ROE | 39.66% | -43.11% |
| ROIC | 26.14% | -40.52% |
Growth (annualized)
| Metric | CGEN | NAUT |
|---|---|---|
| Revenue CAGR (5Y) | 105.91% | N/A |
| Total return CAGR (5Y) | -18.39% | -20.56% |
Frequently asked
- Is CGEN or NAUT more profitable?
- CGEN runs the higher net margin — CGEN at 47.55% versus NAUT at -29747.89%.
- How have CGEN and NAUT total returns compared?
- Over the past 5 years, CGEN delivered -18.39% and NAUT delivered -20.56% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Compugen P/E ratioCompugen ROENautilus Biotechnolgy ROECompugen operating marginNautilus Biotechnolgy operating marginCompugen revenue growthNautilus Biotechnolgy revenue growthCompugen free cash flowNautilus Biotechnolgy free cash flow
Compugen & Nautilus Biotechnolgy appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.